AI주식인사이트AI Stock Insight
C

녹십자홀딩스

005250KOSPI회사 본부 및 경영 컨설팅 서비스업

45.8 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40
News Sentiment18.8 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Plunged 27.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung Biologics Holdings Co., Ltd. is a holding company established in 2001, managing 54 subsidiaries across five business segments, including pharmaceuticals, diagnostics, and healthcare services. While the holding company oversees strategic planning and portfolio management, subsidiaries handle operational activities. The company has expanded its domestic and international revenue and asset base.

Number of Employees

163people

Average Salary

78.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 4.574.0Point
PBR
0.26Industry Average 0.314.0Point

In line with industry avg

ROE
-2.31Industry Average 4.780.0Point

Well below industry avg

Debt Ratio
39.54Industry Average 29.292.0Point

Higher than industry avg (caution)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲236.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -2.2% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 5Neutral 2Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 9,870Won52-week high 17,20052-week low 9,870
1-month return0.0Point

1m -27.48% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral기업지배구조보고서공시2026-06-01
  • Neutral타법인주식및출자증권처분결정(종속회사의주요경영사항)2026-05-27
  • Neutral[기재정정]타법인주식및출자증권처분결정(종속회사의주요경영사항)2026-05-27
  • Neutral분기보고서 (2026.03)2026-05-15